CA2340746A1 - Medical devices with echogenic coatings - Google Patents
Medical devices with echogenic coatings Download PDFInfo
- Publication number
- CA2340746A1 CA2340746A1 CA002340746A CA2340746A CA2340746A1 CA 2340746 A1 CA2340746 A1 CA 2340746A1 CA 002340746 A CA002340746 A CA 002340746A CA 2340746 A CA2340746 A CA 2340746A CA 2340746 A1 CA2340746 A1 CA 2340746A1
- Authority
- CA
- Canada
- Prior art keywords
- echogenic
- particles
- plastic
- reflective particles
- echogenic material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0833—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0833—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
- A61B8/0841—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures for locating instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0108—Steering means as part of the catheter or advancing means; Markers for positioning using radio-opaque or ultrasound markers
Abstract
A medical device for insertion into human body having an echogenic portion of enhanced visibility in an ultrasound scan. The echogenic portion includes an echogenic material comprising a plastic impregnated with sonically reflective particles, the particles having an average size of less than 500 nanometers and formed of a substance having a specific gravity of 5 or greater.
Preferably the particles have an average size of less than 100 nanometers and the sonically reflective particles are 5 % to 40 % of the echogenic material.
Preferably the particles have an average size of less than 100 nanometers and the sonically reflective particles are 5 % to 40 % of the echogenic material.
Description
MEDICAL DEVICES WITH ECHO(~ENIC COATINGS
BACKGROUND OF THE INVENTION
This invention relates generally to medical apparatus such as catheters, needles, electrode leads and other devices which are inserted into a patient's body and more particularly to the provision of echogenic coatings on such devices to enhance their visibility during ultrasonic imaging.
Ultrasonic imaging in the medical field is widely used for a variety of applications. In addition to imaging physiological structures and tissue such as organs, tumors, vessels, and the like, it is often desirable for a physician or technician to have an image of a medical device which has been inserted into the tissue or passageway of a patient. A variety of approaches have been used to enhance ultrasonic imaging of devices by increasing the acoustic reflection coefficient of the devices. In U.S. Pat.
No. 4,401,124 issued to Guess et al., the reflection coefficient of a biopsy needle is enhanced by the use of a diffraction grating disposed on the surface of the needle. A
variety of mechanisms for enhancing the ultrasound image of a portion of a medical instrument are also disclosed in U.S. Patent No. 5,289,831 issued to Bosley, U.S.
Patent No. 5,201,314 issued to Bosley et al. and U.S. Patent No. 5,081,997, also issued to Bosley et al. These patents disclose catheters and other devices provided 2o with cchogenic surfaces including spherical indentations or projections in the range of .5 to 100 microns or fabricated of material incorporating glass spheres or high density metal particles in the range of .5 to 100 microns. The use of micro-bubbles introduced into polymers to provide echogenic catheter components is described in U.S.
Patent No. 5,327,891, issued to Rammler.
SUMMARY OF THE INVENTION
The present invention is directed toward medical devices such catheters, biopsy needles, electrode leads, stems, dilators, cannulae and other medical devices 3o employed within the human body which have enhanced ultrasound visibility by virtue of incoporation of an echogenic material. The material is fabricated by incorporating nanometer sized particles of sonically reflective materials, for example iron oxide, titanium oxide or zinc oxide into a bioeompatible plastic. In one method of fabrication, the reflective particles are mixed with a powdered thermoplastic or thermosetting material such as a polyether amide, a polyurethane or an epoxy , or polyvinylchloridefollowed by thernial processing of the mixture to provide a material of increased sonic reflectance which may be applied as a coating on medical devices of the type discussed above or may be incorporated as a structural component of the medical devices. In a second method of fabrication, the reflective particles are mixed with a self curing polymer such as an epoxy or liquid silicone rubber, followed by curing the mixture in a mold or on or in a device component to provide an echogenic l0 device component of the desired configuration.
By employing particles in the submicron range, preferably in the manometer size range, a substantial amount of the sonically reflective material may be incorporated into the thermoplastic without significantly degrading its bulk properties or affecting its ability to be processed using conventional thermal processing techniques, including molding and extrusion. The use of particles in the manometer range in particular allows for an increased degree of resolution of geometry of the device in an ultrasound scan. Average panicle sizes are sub-micron, preferably less than 500 manometers, more preferably in the tens of manometers, for example 10 manometers. In order to provide for a high degree of ultrasound visibility, and the particles are preferably formed of materials having a specific gravity greater than 5 and may be, for example, zinc oxide, iron oxide, titanium oxide or the like.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure I is a plan drawing of a biopsy needle in which the invention is practiced.
Figure 2 is a cross section through the distal portion of the biopsy needle of Figure I.
Figure 3 is a plan drawing of a medical electrode lead in which the present invention may be practiced.
BACKGROUND OF THE INVENTION
This invention relates generally to medical apparatus such as catheters, needles, electrode leads and other devices which are inserted into a patient's body and more particularly to the provision of echogenic coatings on such devices to enhance their visibility during ultrasonic imaging.
Ultrasonic imaging in the medical field is widely used for a variety of applications. In addition to imaging physiological structures and tissue such as organs, tumors, vessels, and the like, it is often desirable for a physician or technician to have an image of a medical device which has been inserted into the tissue or passageway of a patient. A variety of approaches have been used to enhance ultrasonic imaging of devices by increasing the acoustic reflection coefficient of the devices. In U.S. Pat.
No. 4,401,124 issued to Guess et al., the reflection coefficient of a biopsy needle is enhanced by the use of a diffraction grating disposed on the surface of the needle. A
variety of mechanisms for enhancing the ultrasound image of a portion of a medical instrument are also disclosed in U.S. Patent No. 5,289,831 issued to Bosley, U.S.
Patent No. 5,201,314 issued to Bosley et al. and U.S. Patent No. 5,081,997, also issued to Bosley et al. These patents disclose catheters and other devices provided 2o with cchogenic surfaces including spherical indentations or projections in the range of .5 to 100 microns or fabricated of material incorporating glass spheres or high density metal particles in the range of .5 to 100 microns. The use of micro-bubbles introduced into polymers to provide echogenic catheter components is described in U.S.
Patent No. 5,327,891, issued to Rammler.
SUMMARY OF THE INVENTION
The present invention is directed toward medical devices such catheters, biopsy needles, electrode leads, stems, dilators, cannulae and other medical devices 3o employed within the human body which have enhanced ultrasound visibility by virtue of incoporation of an echogenic material. The material is fabricated by incorporating nanometer sized particles of sonically reflective materials, for example iron oxide, titanium oxide or zinc oxide into a bioeompatible plastic. In one method of fabrication, the reflective particles are mixed with a powdered thermoplastic or thermosetting material such as a polyether amide, a polyurethane or an epoxy , or polyvinylchloridefollowed by thernial processing of the mixture to provide a material of increased sonic reflectance which may be applied as a coating on medical devices of the type discussed above or may be incorporated as a structural component of the medical devices. In a second method of fabrication, the reflective particles are mixed with a self curing polymer such as an epoxy or liquid silicone rubber, followed by curing the mixture in a mold or on or in a device component to provide an echogenic l0 device component of the desired configuration.
By employing particles in the submicron range, preferably in the manometer size range, a substantial amount of the sonically reflective material may be incorporated into the thermoplastic without significantly degrading its bulk properties or affecting its ability to be processed using conventional thermal processing techniques, including molding and extrusion. The use of particles in the manometer range in particular allows for an increased degree of resolution of geometry of the device in an ultrasound scan. Average panicle sizes are sub-micron, preferably less than 500 manometers, more preferably in the tens of manometers, for example 10 manometers. In order to provide for a high degree of ultrasound visibility, and the particles are preferably formed of materials having a specific gravity greater than 5 and may be, for example, zinc oxide, iron oxide, titanium oxide or the like.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure I is a plan drawing of a biopsy needle in which the invention is practiced.
Figure 2 is a cross section through the distal portion of the biopsy needle of Figure I.
Figure 3 is a plan drawing of a medical electrode lead in which the present invention may be practiced.
Figures 4 and 5 are cross sections through the distal portion of the lead, showing alternate mechanisms by which the present invention may be incorporated into the lead.
Figures 6, 7, 8 and 9 are cross-sections through catheter bodies incorporating the present invention.
Figure 10 is a functional flow chart illustrating a first process of manufacturing devices according to the present invention.
Figure 11 is a functional flow chart illustrating a second process of manufacturing devices according to the present invention.
l0 Figure 12 is a diagram illustrating the use of the present invention to assist localization of a medical device inserted in a patient's body.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
Figure I is a plan view of a biopsy needle incorporating the present invention.
At the proximal end, the needle is provided with a plastic fitting 10, from which a stainless steel hollow needle 12 extends. Slightly distal to the sharpened distal tip 16 of the needle is a coating or sleeve 14 of echogenic material fabricated according to the present invention. The echogenic material, as discussed above, is fabricated of a 2o plastic containing nanometer sized particles of material having a specific gravity of 5 or greater. The reflective material may either be applied to the needle as a coating, may be a molded or extruded sleeve, expanded and then shrunk around needle 12, extruded over needle 12 or adhesively bonded to needle 12 in order to maintain it in tight engagement with the surface of the needle. The needle may also be provided with a circumferential recess in which the sleeve or coating is applied.
Alternatively, the thickness of the sleeve or coating may decrease at its proximal and distal ends to provide for a smooth outer surface. As yet an additional alternative, the coating or sleeve 14 may extend proximally all the way back to or closely adjacent to the distal end of fitting 10.
3o Figure 2 illustrates the needle in cross-section in which the coating or sleeve l4 is applied over tubular needle 12. An appropriate thickness for the coating or sleeve may be, for example, .002 inches to .010 inches. The material may be fabricated according to the examples described below.
Figure 3 is a plan view of an implantable electrode lead, in this case a cardiac pacing lead, in which the invention is employed. The lead is provided with a connector assembly 16 which carries a conductive connector ring 18 and a conductive connector pin 20. Sealing rings 22 and 24 assist in seating the electrode lead in a corresponding connector block of an implantable medical device such as an implantable pacemaker, cardioverter or defibrillator. Extending distally from the connector assembly 16 is an elongated lead insulative lead body 26 which may be fabricated of polyurethane, silicone rubber or any of the various materials typically employed to manufacture implantable electrode leads. The lead carries electrode 28 at its distal tip coupled to connector pin 20 by means of a conductor within lead body 26 and a ring electrode 30 located proximal thereto and coupled to connector ring 18 by means of a conductor within lead body 26. The portion 32 of the lead between the ring electrode 30 and the tip electrode 28, typically referred to as a tip-ring spacer, is the portion of the lead having enhanced echogenicity according to the present invention.
Figure 4 illustrates a cross-section through the tip-ring spacer 32 of a first embodiment of a lead according to Figure 3. In this embodiment, this portion of the lead has a two layer structure comprising an inner polymer tube 38 and an outer polymer tube or sleeve 34, surrounding an internal coiled conductor 36 which couples tip electrode 28 to connector pin 20 (Fig. 3}. In this embodiment, one of the inner tubular member 38 or the outer sleeve or coating 34 may be fabricated of a material according to the present invention, having increased echogenicity, with the other of the inner tubular member 38 fabricated of a biocompatible polymer such as polyurethane or silicone rubber.
Figure 5 illustrates a cross-section through an alternative of an embodiment of a lead according to Figure 3, employing the present invention. In this case, the tip-ring space region includes only a single extruded tubular member 40, fabricated of echogenic material according to the present invention, enclosing conductor coil 36.
An additional, un-illustrated alternative would be to place the echogenic material in a lumen within the lead body.
Figures 6, 7, 8 and 9 show alternative cross-sections through single and multi-lumen cannula or catheter bodies including echogenic materials fabricated according to the present invention. In Figure 6, the catheter or cannula body is fabricated of an elongated tubular extrusion 42 surrounded by an outer sleeve or coating 44, either of 5 which may be fabricated of echogenic material produced according to the present invention. Figure 7 illustrates a cross-section of a multi-lumen cannula or catheter body, taking the forn~ of an extruded bi-lumen tube 46, fabricated entirely of an echogenic material according to the present invention. Figure 8 illustrates a two-piece multi-lumen catheter or cannula body fabricated having an inner, extruded, Y-shaped 1o strut 48, surrounded by an outer extruded tube 50, either of which may be fabricated of an echogenic material produced according to the present invention. Figure illustrates a mufti-lumen cannula or catheter body 49 fabricated of an extruded bi-lumen tube having an one lumen filled with an echogenic material 47 according to the present invention. The echogenic material 47 may be co-extruded extruded with the catheter or cannula body or may be inserted into as lumen of a previously formed catheter or cannula body.
Figure 10 is a functional flow chart illustrating one process of producing an single or mufti-lumen tube, rod or other device component fabricated of an echogenic material according to the present invention. At 100, a desired thermoplastic resin in powdered or granular form is mixed with nanometer sized particles of a material having a specific gravity of 5 or more, such as iron oxide or zinc oxide.
Additional materials appropriate for use in conjunction with the present invention include titanium oxide, silver oxide and platinum oxide. Appropriate thermoplastics include polyether amides, a polyether block amides, polyvinyl chlorides, polyurethanes and the like. Alternatively, a thermosetting resin such as an epoxy may be employed by mixing the particles with the liquid components of the resin. The resultant mixture is then thermally processed by heating at 102 and extruded and/or molded at 104 to form a tube, rod, sheet, or molded piece part. The resulting forn~ed polymer is incorporated into the device at 106 and the device is thereafter sterilized and packaged at 108. Specific examples of materials so formed are set forth below.
Figure 11 is a functional flow chart illustrating the process of producing an medical device having a piece part or coating fabricated of an echogenic material WO 00/09178 1'CT/US99/17260 G
according to the present 111veI1t10I1 uSlng a plastic which cures at room temperature, such as liquid silicone rubber, epoxies and the like. At 200, the desired plastic resin in liquid form is mixed with manometer sized particles of a material having a specific gravity of 5 or more, such as discussed above. The resultant mixture is then formed to display its desired physical configuration by being applied to the surface or interior of a component of the medical device or by being placed in a mold at 202 to form a tube, rod, sheet, or molded piece part and allowed to cure at 204. The resulting formed polymer is incorporated into the device at 206 and the device is thereafter sterilized and packaged at 208. Specific examples of materials so formed are also set forth 1o below.
Example 1 630 grams of powdered PEBAX ~ No 5533501 polymer, a polyether block amide available from Elf Atochem, may be placed in a polyester mesh bag and dried overnight in a desiccated air dryer operating at -40° F dew point and at 170°F. To the dried PE.BAX may be added 70 grams of NanoTekO zinc oxide having an average particle size of 36 manometers, available from Nanophase Technology Corporation, Burridgc, Illinois and the resulting blend may be mixed by tumbling. The PEBAX
polymer is suitable for molding and extrusion processes to produce piece parts and 2o films, sheaths, filaments, tubes, sheets and the like. The resultant mixture may then be melt processed on a 34 millimeter twin screw Haake Rhcocord Rheometer by slowly feeding the blend into the throat of the extruder. The extruder may be set to operate at SO revolutions per minute, and the melt profile may be zone 1: 190° C, zone 2: 190°
C, zone 3: 220° C and final melt: 220° C. The polymer may be extruded directly into the form in which it will be incorporated into a medical device, for example, as a tube or rod, or may be subsequently processed by being chopped into pellets and employed in use in a subsequent extrusion process, molding process or other thermal processing technique. The material produced comprises 10% by weight zinc oxide and is readily extrudable.
Example 2 As an alternative, 52 grams of the NanoTek ~ zinc oxide may be combined with 647.5 grams of the PEBAX ~ polymer, dried, mixed and thermally processed as described above. The material produced comprises 7.~% by weight zinc oxide and is readily cxtrudable.
Example 3 Corresponding materials may be fabricated employing iron oxide, for example, NanoTck ~t iron oxide produced by Nanophase Technology, having a typical average particle size of 26 nanometers, may also be employed in like percentages and 1o using like procedures to provide an echogenic coating or component for use in a medical device. Other sub-micron sized materials, preferably having specific gravities of S or greater, for example platinum oxide, titanium dioxide, silver oxide and the like, can be substituted for the iron oxide or zinc oxide.
Examples 4- 6 Liquid silicone rubber may be mixed with the NanoTek~ titanium dioxide powder having a average particle size of 20 nanometcrs in a 4:1 ratio by weight. The resulting mixture may be introduced into a tubular mold and allowed to cure at room temperature. Alternatively, Dupont TI-PUREO titanium dioxide having an average 2o particle size of 340 nanometers, available from Dupont, Inc., Wilmington Delaware or titanium dioxide powder having an average particle size of 25 nanometers, available from Degussa Corporation, Ridgefield New Jersey may be blended in like quantities with liquid silicone rubber.
Examples 7- 9 Liquid silicone rubber may be mixed with the NanoTekO zinc oxide powder having a average particle size of 20 nanomcters in a 4:1 ratio by weight. The resulting mixture may be introduced into a tubular mold and allowed to cure at room temperature. Alternatively, zinc oxide powder having an average particle size of 450 3o nanometcrs, available from Aldrich Corp., Milwaukee, Wisconsin or zinc oxide powder having an average particle size of 310 nanometers, available from Strem H
Chemicals, Newburyport Massachusetts may be blended in like quantities with liquid silicone rubber.
In tests imaging tubes made according to examples 4 - 9 using a 7.5 megaherz ultrasound probe, it was observed that all samples were visible with adequate brightness. Further, in viewing the tubes with the probe held parallel to the axis of the tubes, the tubes made employing the smaller particles produced by Nanophase Corporation were visible with a higher degree of resolution, enabling both the near and far walls of the tubes to be visualized.
l0 Example 10 Any of the reflective powders referred to in Examples 4 - 9 may be mixed in like quantities with one or both of the hardener and resin of a two-part epoxy such as sold under the brand name HYSOLO, manufactured by the Dexter corporation, Windsor Locks, Connecticut. The mixture may be place in a~mold or applied to the interior or exterior of a medical device component and allowed to cure.
Figure 12 illustrates the overall method of use of the device according to the present invention. In this case, a pacing lead 110 is shown being placed within the heart 112 of a patient 114 while being monitored ultrasonically. The distal portion 116 of the lead is provided with a coating of echogenic material or is fabricated of echogenic material according to the present invention, rendering it visible on ultrasound imaging system 118. The echogenic material according to the present invention may thus be usefully substituted for or used in addition to radiopaque materials typically employed to increase the fluoroscopic visibility of medical devices within the human body. Because ultrasound imaging systems are substantially less expensive than fluoroscopes and are available in clinics and hospitals worldwide where fluoroscopy may not be available, the fabrication of devices according to the present invention is believed to provide a substantial benefit both in reducing the costs associated with medical procedures employing the devices and increasing the number of physicians and facilities capable of employing the devices.
While the specific examples given above which employ the preferred nanometer sized sonically reflective particles employ particles having average particle sizes of 20, 26 and 36 nanometers, it is believed that other nanometer sized particles having average sizes less than 100 manometers, preferably in the tens of manometers, and preferably having a specific gravity of 5 or greater may be substituted for those specifically discussed above with similarly desirable results. Similarly, while the particles in the above examples comprised 7.5 - 20 % of the weight of the materials, it is believed that materials constituting 2% to 40% by weight of sonically reflective particles may also be usefully employed. Therefore, the specific examples given to above should be considered exemplary, rather than limiting, with regard to the claims which follow.
In conjunction with the above application, we claim:
Figures 6, 7, 8 and 9 are cross-sections through catheter bodies incorporating the present invention.
Figure 10 is a functional flow chart illustrating a first process of manufacturing devices according to the present invention.
Figure 11 is a functional flow chart illustrating a second process of manufacturing devices according to the present invention.
l0 Figure 12 is a diagram illustrating the use of the present invention to assist localization of a medical device inserted in a patient's body.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
Figure I is a plan view of a biopsy needle incorporating the present invention.
At the proximal end, the needle is provided with a plastic fitting 10, from which a stainless steel hollow needle 12 extends. Slightly distal to the sharpened distal tip 16 of the needle is a coating or sleeve 14 of echogenic material fabricated according to the present invention. The echogenic material, as discussed above, is fabricated of a 2o plastic containing nanometer sized particles of material having a specific gravity of 5 or greater. The reflective material may either be applied to the needle as a coating, may be a molded or extruded sleeve, expanded and then shrunk around needle 12, extruded over needle 12 or adhesively bonded to needle 12 in order to maintain it in tight engagement with the surface of the needle. The needle may also be provided with a circumferential recess in which the sleeve or coating is applied.
Alternatively, the thickness of the sleeve or coating may decrease at its proximal and distal ends to provide for a smooth outer surface. As yet an additional alternative, the coating or sleeve 14 may extend proximally all the way back to or closely adjacent to the distal end of fitting 10.
3o Figure 2 illustrates the needle in cross-section in which the coating or sleeve l4 is applied over tubular needle 12. An appropriate thickness for the coating or sleeve may be, for example, .002 inches to .010 inches. The material may be fabricated according to the examples described below.
Figure 3 is a plan view of an implantable electrode lead, in this case a cardiac pacing lead, in which the invention is employed. The lead is provided with a connector assembly 16 which carries a conductive connector ring 18 and a conductive connector pin 20. Sealing rings 22 and 24 assist in seating the electrode lead in a corresponding connector block of an implantable medical device such as an implantable pacemaker, cardioverter or defibrillator. Extending distally from the connector assembly 16 is an elongated lead insulative lead body 26 which may be fabricated of polyurethane, silicone rubber or any of the various materials typically employed to manufacture implantable electrode leads. The lead carries electrode 28 at its distal tip coupled to connector pin 20 by means of a conductor within lead body 26 and a ring electrode 30 located proximal thereto and coupled to connector ring 18 by means of a conductor within lead body 26. The portion 32 of the lead between the ring electrode 30 and the tip electrode 28, typically referred to as a tip-ring spacer, is the portion of the lead having enhanced echogenicity according to the present invention.
Figure 4 illustrates a cross-section through the tip-ring spacer 32 of a first embodiment of a lead according to Figure 3. In this embodiment, this portion of the lead has a two layer structure comprising an inner polymer tube 38 and an outer polymer tube or sleeve 34, surrounding an internal coiled conductor 36 which couples tip electrode 28 to connector pin 20 (Fig. 3}. In this embodiment, one of the inner tubular member 38 or the outer sleeve or coating 34 may be fabricated of a material according to the present invention, having increased echogenicity, with the other of the inner tubular member 38 fabricated of a biocompatible polymer such as polyurethane or silicone rubber.
Figure 5 illustrates a cross-section through an alternative of an embodiment of a lead according to Figure 3, employing the present invention. In this case, the tip-ring space region includes only a single extruded tubular member 40, fabricated of echogenic material according to the present invention, enclosing conductor coil 36.
An additional, un-illustrated alternative would be to place the echogenic material in a lumen within the lead body.
Figures 6, 7, 8 and 9 show alternative cross-sections through single and multi-lumen cannula or catheter bodies including echogenic materials fabricated according to the present invention. In Figure 6, the catheter or cannula body is fabricated of an elongated tubular extrusion 42 surrounded by an outer sleeve or coating 44, either of 5 which may be fabricated of echogenic material produced according to the present invention. Figure 7 illustrates a cross-section of a multi-lumen cannula or catheter body, taking the forn~ of an extruded bi-lumen tube 46, fabricated entirely of an echogenic material according to the present invention. Figure 8 illustrates a two-piece multi-lumen catheter or cannula body fabricated having an inner, extruded, Y-shaped 1o strut 48, surrounded by an outer extruded tube 50, either of which may be fabricated of an echogenic material produced according to the present invention. Figure illustrates a mufti-lumen cannula or catheter body 49 fabricated of an extruded bi-lumen tube having an one lumen filled with an echogenic material 47 according to the present invention. The echogenic material 47 may be co-extruded extruded with the catheter or cannula body or may be inserted into as lumen of a previously formed catheter or cannula body.
Figure 10 is a functional flow chart illustrating one process of producing an single or mufti-lumen tube, rod or other device component fabricated of an echogenic material according to the present invention. At 100, a desired thermoplastic resin in powdered or granular form is mixed with nanometer sized particles of a material having a specific gravity of 5 or more, such as iron oxide or zinc oxide.
Additional materials appropriate for use in conjunction with the present invention include titanium oxide, silver oxide and platinum oxide. Appropriate thermoplastics include polyether amides, a polyether block amides, polyvinyl chlorides, polyurethanes and the like. Alternatively, a thermosetting resin such as an epoxy may be employed by mixing the particles with the liquid components of the resin. The resultant mixture is then thermally processed by heating at 102 and extruded and/or molded at 104 to form a tube, rod, sheet, or molded piece part. The resulting forn~ed polymer is incorporated into the device at 106 and the device is thereafter sterilized and packaged at 108. Specific examples of materials so formed are set forth below.
Figure 11 is a functional flow chart illustrating the process of producing an medical device having a piece part or coating fabricated of an echogenic material WO 00/09178 1'CT/US99/17260 G
according to the present 111veI1t10I1 uSlng a plastic which cures at room temperature, such as liquid silicone rubber, epoxies and the like. At 200, the desired plastic resin in liquid form is mixed with manometer sized particles of a material having a specific gravity of 5 or more, such as discussed above. The resultant mixture is then formed to display its desired physical configuration by being applied to the surface or interior of a component of the medical device or by being placed in a mold at 202 to form a tube, rod, sheet, or molded piece part and allowed to cure at 204. The resulting formed polymer is incorporated into the device at 206 and the device is thereafter sterilized and packaged at 208. Specific examples of materials so formed are also set forth 1o below.
Example 1 630 grams of powdered PEBAX ~ No 5533501 polymer, a polyether block amide available from Elf Atochem, may be placed in a polyester mesh bag and dried overnight in a desiccated air dryer operating at -40° F dew point and at 170°F. To the dried PE.BAX may be added 70 grams of NanoTekO zinc oxide having an average particle size of 36 manometers, available from Nanophase Technology Corporation, Burridgc, Illinois and the resulting blend may be mixed by tumbling. The PEBAX
polymer is suitable for molding and extrusion processes to produce piece parts and 2o films, sheaths, filaments, tubes, sheets and the like. The resultant mixture may then be melt processed on a 34 millimeter twin screw Haake Rhcocord Rheometer by slowly feeding the blend into the throat of the extruder. The extruder may be set to operate at SO revolutions per minute, and the melt profile may be zone 1: 190° C, zone 2: 190°
C, zone 3: 220° C and final melt: 220° C. The polymer may be extruded directly into the form in which it will be incorporated into a medical device, for example, as a tube or rod, or may be subsequently processed by being chopped into pellets and employed in use in a subsequent extrusion process, molding process or other thermal processing technique. The material produced comprises 10% by weight zinc oxide and is readily extrudable.
Example 2 As an alternative, 52 grams of the NanoTek ~ zinc oxide may be combined with 647.5 grams of the PEBAX ~ polymer, dried, mixed and thermally processed as described above. The material produced comprises 7.~% by weight zinc oxide and is readily cxtrudable.
Example 3 Corresponding materials may be fabricated employing iron oxide, for example, NanoTck ~t iron oxide produced by Nanophase Technology, having a typical average particle size of 26 nanometers, may also be employed in like percentages and 1o using like procedures to provide an echogenic coating or component for use in a medical device. Other sub-micron sized materials, preferably having specific gravities of S or greater, for example platinum oxide, titanium dioxide, silver oxide and the like, can be substituted for the iron oxide or zinc oxide.
Examples 4- 6 Liquid silicone rubber may be mixed with the NanoTek~ titanium dioxide powder having a average particle size of 20 nanometcrs in a 4:1 ratio by weight. The resulting mixture may be introduced into a tubular mold and allowed to cure at room temperature. Alternatively, Dupont TI-PUREO titanium dioxide having an average 2o particle size of 340 nanometers, available from Dupont, Inc., Wilmington Delaware or titanium dioxide powder having an average particle size of 25 nanometers, available from Degussa Corporation, Ridgefield New Jersey may be blended in like quantities with liquid silicone rubber.
Examples 7- 9 Liquid silicone rubber may be mixed with the NanoTekO zinc oxide powder having a average particle size of 20 nanomcters in a 4:1 ratio by weight. The resulting mixture may be introduced into a tubular mold and allowed to cure at room temperature. Alternatively, zinc oxide powder having an average particle size of 450 3o nanometcrs, available from Aldrich Corp., Milwaukee, Wisconsin or zinc oxide powder having an average particle size of 310 nanometers, available from Strem H
Chemicals, Newburyport Massachusetts may be blended in like quantities with liquid silicone rubber.
In tests imaging tubes made according to examples 4 - 9 using a 7.5 megaherz ultrasound probe, it was observed that all samples were visible with adequate brightness. Further, in viewing the tubes with the probe held parallel to the axis of the tubes, the tubes made employing the smaller particles produced by Nanophase Corporation were visible with a higher degree of resolution, enabling both the near and far walls of the tubes to be visualized.
l0 Example 10 Any of the reflective powders referred to in Examples 4 - 9 may be mixed in like quantities with one or both of the hardener and resin of a two-part epoxy such as sold under the brand name HYSOLO, manufactured by the Dexter corporation, Windsor Locks, Connecticut. The mixture may be place in a~mold or applied to the interior or exterior of a medical device component and allowed to cure.
Figure 12 illustrates the overall method of use of the device according to the present invention. In this case, a pacing lead 110 is shown being placed within the heart 112 of a patient 114 while being monitored ultrasonically. The distal portion 116 of the lead is provided with a coating of echogenic material or is fabricated of echogenic material according to the present invention, rendering it visible on ultrasound imaging system 118. The echogenic material according to the present invention may thus be usefully substituted for or used in addition to radiopaque materials typically employed to increase the fluoroscopic visibility of medical devices within the human body. Because ultrasound imaging systems are substantially less expensive than fluoroscopes and are available in clinics and hospitals worldwide where fluoroscopy may not be available, the fabrication of devices according to the present invention is believed to provide a substantial benefit both in reducing the costs associated with medical procedures employing the devices and increasing the number of physicians and facilities capable of employing the devices.
While the specific examples given above which employ the preferred nanometer sized sonically reflective particles employ particles having average particle sizes of 20, 26 and 36 nanometers, it is believed that other nanometer sized particles having average sizes less than 100 manometers, preferably in the tens of manometers, and preferably having a specific gravity of 5 or greater may be substituted for those specifically discussed above with similarly desirable results. Similarly, while the particles in the above examples comprised 7.5 - 20 % of the weight of the materials, it is believed that materials constituting 2% to 40% by weight of sonically reflective particles may also be usefully employed. Therefore, the specific examples given to above should be considered exemplary, rather than limiting, with regard to the claims which follow.
In conjunction with the above application, we claim:
Claims (19)
1. A medical device for insertion into human body having an echogenic portion of enhanced visibility in an ultrasound scan, wherein the echogenic portion comprises:
an echogenic material comprising a plastic impregnated with sonically reflective particles, the particles having an average size of less than 500 nanometers and formed of a substance having a specific gravity of 5 or greater.
an echogenic material comprising a plastic impregnated with sonically reflective particles, the particles having an average size of less than 500 nanometers and formed of a substance having a specific gravity of 5 or greater.
2. A device according to claim 1 wherein the particles have an average size of less than 100 nanometers.
3. A medical device for insertion into human body having an echogenic portion of enhanced visibility in an ultrasound scan, wherein the echogenic portion comprises:
an echogenic material comprising a plastic impregnated with sonically reflective particles, the particles having an average size of less than 100 nanometers.
an echogenic material comprising a plastic impregnated with sonically reflective particles, the particles having an average size of less than 100 nanometers.
4. A device according to claim 1 or claim 2 claim 3 wherein the sonically reflective particles are 5% to 40% of the echogenic material.
5. A device according to claim 4 wherein the sonically reflective particles are formed of zinc oxide.
6. A device according to claim 4 wherein the sonically reflective particles are formed of iron oxide.
7. A device according to claim 4 wherein the sonically reflective particles are formed of titanium dioxide.
8. A device according to claim 4 wherein the sonically reflective particles are formed of platinum oxide.
9. A device according to claim 4 wherein the sonically reflective particles are formed of silver oxide.
10. A device according to claim 1 or claim 3 wherein the plastic is a thermoplastic.
11. A device according to claim 10 wherein the plastic is a polyether block amide.
12. A device according to claim 1 or claim 3 wherein the plastic is an epoxy.
13. A device according to claim 1 or claim 3 wherein the plastic is self-curing.
14. A device according to claim 13 wherein the plastic is silicone rubber.
15. A device according to claim 1 or claim 3 wherein the plastic is a thermosetting plastic.
16. A device according to claim 1 or claim 3 wherein the device comprises an elongated needle provided with a sleeve or coating of said echogenic material.
17. A device according to claim 1 or claim 3 wherein said device comprises an elongated device body and wherein the echogenic material comprises a portion of the device body.
18. A device according to claim 1 or claim 3 wherein the device comprises an elongated device body, and wherein the echogenic material is applied to the exterior of the elongated device body.
19. A device according to claim 1 or claim 3 wherein said device comprises an elongated device body and wherein the echogenic material is located interior to the elongated body.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/135,468 | 1998-08-17 | ||
US09/135,468 US5921933A (en) | 1998-08-17 | 1998-08-17 | Medical devices with echogenic coatings |
PCT/US1999/017260 WO2000009178A1 (en) | 1998-08-17 | 1999-07-29 | Medical devices with echogenic coatings |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2340746A1 true CA2340746A1 (en) | 2000-02-24 |
Family
ID=22468239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002340746A Abandoned CA2340746A1 (en) | 1998-08-17 | 1999-07-29 | Medical devices with echogenic coatings |
Country Status (6)
Country | Link |
---|---|
US (1) | US5921933A (en) |
EP (1) | EP1105170B1 (en) |
JP (1) | JP2002522167A (en) |
CA (1) | CA2340746A1 (en) |
DE (1) | DE69907475T2 (en) |
WO (1) | WO2000009178A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD669577S1 (en) | 2003-11-05 | 2012-10-23 | Kimberly-Clark Worldwide, Inc. | Cannula with band markings |
Families Citing this family (151)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8668737B2 (en) | 1997-10-10 | 2014-03-11 | Senorx, Inc. | Tissue marking implant |
US7637948B2 (en) | 1997-10-10 | 2009-12-29 | Senorx, Inc. | Tissue marking implant |
US5921933A (en) * | 1998-08-17 | 1999-07-13 | Medtronic, Inc. | Medical devices with echogenic coatings |
US6254601B1 (en) * | 1998-12-08 | 2001-07-03 | Hysterx, Inc. | Methods for occlusion of the uterine arteries |
US20090030309A1 (en) | 2007-07-26 | 2009-01-29 | Senorx, Inc. | Deployment of polysaccharide markers |
US7983734B2 (en) | 2003-05-23 | 2011-07-19 | Senorx, Inc. | Fibrous marker and intracorporeal delivery thereof |
US8361082B2 (en) | 1999-02-02 | 2013-01-29 | Senorx, Inc. | Marker delivery device with releasable plug |
US6862470B2 (en) | 1999-02-02 | 2005-03-01 | Senorx, Inc. | Cavity-filling biopsy site markers |
US6725083B1 (en) | 1999-02-02 | 2004-04-20 | Senorx, Inc. | Tissue site markers for in VIVO imaging |
US8498693B2 (en) | 1999-02-02 | 2013-07-30 | Senorx, Inc. | Intracorporeal marker and marker delivery device |
US7651505B2 (en) | 2002-06-17 | 2010-01-26 | Senorx, Inc. | Plugged tip delivery for marker placement |
US9820824B2 (en) | 1999-02-02 | 2017-11-21 | Senorx, Inc. | Deployment of polysaccharide markers for treating a site within a patent |
US6689142B1 (en) * | 1999-04-26 | 2004-02-10 | Scimed Life Systems, Inc. | Apparatus and methods for guiding a needle |
DE19921088C2 (en) * | 1999-04-30 | 2003-08-07 | Magforce Applic Gmbh | Stent to keep aisle-like structures open |
US6575991B1 (en) * | 1999-06-17 | 2003-06-10 | Inrad, Inc. | Apparatus for the percutaneous marking of a lesion |
US6358211B1 (en) * | 1999-10-12 | 2002-03-19 | Scimed Life Systems, Inc. | Ultrasound lucent apparatus and methods of using |
US6506156B1 (en) | 2000-01-19 | 2003-01-14 | Vascular Control Systems, Inc | Echogenic coating |
US6577904B1 (en) | 2000-03-30 | 2003-06-10 | Cardiac Pacemakers, Inc. | Ultrasound echogenic cardiac lead |
US7223279B2 (en) * | 2000-04-21 | 2007-05-29 | Vascular Control Systems, Inc. | Methods for minimally-invasive, non-permanent occlusion of a uterine artery |
US20030120306A1 (en) * | 2000-04-21 | 2003-06-26 | Vascular Control System | Method and apparatus for the detection and occlusion of blood vessels |
US6550482B1 (en) | 2000-04-21 | 2003-04-22 | Vascular Control Systems, Inc. | Methods for non-permanent occlusion of a uterine artery |
FR2810247B1 (en) * | 2000-06-14 | 2008-07-25 | Prodimed | OPAQUE ECHOGENE AND / OR RADIO DEVICE FOR THE COLLECTION OR TRANSFER IN GENITAL ORGANS |
US6635065B2 (en) | 2000-11-16 | 2003-10-21 | Vascular Control Systems, Inc. | Doppler directed suture ligation device and method |
US6638286B1 (en) | 2000-11-16 | 2003-10-28 | Vascular Control Systems, Inc. | Doppler directed suture ligation device and method |
EP1919388B1 (en) | 2000-11-20 | 2012-12-26 | Senorx, Inc. | Tissue site markers for in vivo imaging |
US7014610B2 (en) * | 2001-02-09 | 2006-03-21 | Medtronic, Inc. | Echogenic devices and methods of making and using such devices |
US20020138136A1 (en) * | 2001-03-23 | 2002-09-26 | Scimed Life Systems, Inc. | Medical device having radio-opacification and barrier layers |
US20030120286A1 (en) * | 2001-03-28 | 2003-06-26 | Vascular Control System | Luminal clip applicator with sensor |
WO2002078549A2 (en) | 2001-03-28 | 2002-10-10 | Vascular Control Systems, Inc. | Method and apparatus for the detection and ligation of uterine arteries |
US7354444B2 (en) * | 2001-03-28 | 2008-04-08 | Vascular Control Systems, Inc. | Occlusion device with deployable paddles for detection and occlusion of blood vessels |
US6723052B2 (en) | 2001-06-07 | 2004-04-20 | Stanley L. Mills | Echogenic medical device |
US7286877B2 (en) * | 2001-07-13 | 2007-10-23 | Cardiac Pacemakers, Inc. | Device programmer with enclosed imaging capability |
US6704600B2 (en) | 2001-07-13 | 2004-03-09 | Cardiac Pacemakers, Inc. | Device programmer with enclosed imaging capability |
GB0120645D0 (en) | 2001-08-24 | 2001-10-17 | Smiths Group Plc | Medico-surgical devices |
GB0121690D0 (en) * | 2001-09-08 | 2001-10-31 | Smiths Group Plc | Medico-surgical devices |
GB0123596D0 (en) * | 2001-10-02 | 2001-11-21 | Smiths Group Plc | Medico-surgical devices |
EP1429683B1 (en) * | 2001-09-28 | 2014-12-24 | Boston Scientific Limited | Medical devices comprising nanomaterials and therapeutic methods utilizing the same |
US7065394B2 (en) * | 2001-12-12 | 2006-06-20 | Medtronic, Inc | Guide catheter |
US20040073158A1 (en) * | 2001-12-12 | 2004-04-15 | Medtronic, Inc. | Guide catheter |
US7169155B2 (en) * | 2001-12-14 | 2007-01-30 | Scimed Life Systems, Inc. | Methods and apparatus for guiding a needle |
US7207996B2 (en) * | 2002-04-04 | 2007-04-24 | Vascular Control Systems, Inc. | Doppler directed suturing and compression device and method |
US20030199887A1 (en) * | 2002-04-23 | 2003-10-23 | David Ferrera | Filamentous embolization device and method of use |
US7217426B1 (en) | 2002-06-21 | 2007-05-15 | Advanced Cardiovascular Systems, Inc. | Coatings containing polycationic peptides for cardiovascular therapy |
WO2004043507A1 (en) * | 2002-11-07 | 2004-05-27 | Carbon Medical Technologies, Inc. | Biocompatible medical device coatings |
US20060036158A1 (en) | 2003-11-17 | 2006-02-16 | Inrad, Inc. | Self-contained, self-piercing, side-expelling marking apparatus |
US7172603B2 (en) * | 2002-11-19 | 2007-02-06 | Vascular Control Systems, Inc. | Deployable constrictor for uterine artery occlusion |
US20040097961A1 (en) * | 2002-11-19 | 2004-05-20 | Vascular Control System | Tenaculum for use with occlusion devices |
US6936048B2 (en) * | 2003-01-16 | 2005-08-30 | Charlotte-Mecklenburg Hospital Authority | Echogenic needle for transvaginal ultrasound directed reduction of uterine fibroids and an associated method |
US7404821B2 (en) * | 2003-01-30 | 2008-07-29 | Vascular Control Systems, Inc. | Treatment for post partum hemorrhage |
US7651511B2 (en) * | 2003-02-05 | 2010-01-26 | Vascular Control Systems, Inc. | Vascular clamp for caesarian section |
US7333844B2 (en) * | 2003-03-28 | 2008-02-19 | Vascular Control Systems, Inc. | Uterine tissue monitoring device and method |
GB0307350D0 (en) * | 2003-03-29 | 2003-05-07 | Smiths Group Plc | Catheters |
US20040202694A1 (en) * | 2003-04-11 | 2004-10-14 | Vascular Control Systems, Inc. | Embolic occlusion of uterine arteries |
US8791171B2 (en) * | 2003-05-01 | 2014-07-29 | Abbott Cardiovascular Systems Inc. | Biodegradable coatings for implantable medical devices |
CA2524651A1 (en) * | 2003-05-15 | 2004-12-02 | Applied Medical Resources Corporation | Echogenic stent |
US7877133B2 (en) | 2003-05-23 | 2011-01-25 | Senorx, Inc. | Marker or filler forming fluid |
US20040260269A1 (en) * | 2003-06-23 | 2004-12-23 | Yair Assaf | Method for treating false aneurysm and a needle for use in such a method |
JP4256309B2 (en) * | 2003-09-29 | 2009-04-22 | 株式会社東芝 | Ultrasonic probe and ultrasonic diagnostic apparatus |
US20050273002A1 (en) * | 2004-06-04 | 2005-12-08 | Goosen Ryan L | Multi-mode imaging marker |
US7325546B2 (en) * | 2003-11-20 | 2008-02-05 | Vascular Control Systems, Inc. | Uterine artery occlusion device with cervical receptacle |
US7686817B2 (en) * | 2003-11-25 | 2010-03-30 | Vascular Control Systems, Inc. | Occlusion device for asymmetrical uterine artery anatomy |
WO2005058411A1 (en) * | 2003-12-02 | 2005-06-30 | Kansai Technology Licensing Organization Co., Ltd. | Nerve stimulating device-use kit |
US20060015144A1 (en) * | 2004-07-19 | 2006-01-19 | Vascular Control Systems, Inc. | Uterine artery occlusion staple |
JP2006061258A (en) * | 2004-08-25 | 2006-03-09 | Jfe Steel Kk | Medical treatment method using medical ceramic coated needle and method for sampling medical specimen using ceramic coated puncture needle |
US7244443B2 (en) | 2004-08-31 | 2007-07-17 | Advanced Cardiovascular Systems, Inc. | Polymers of fluorinated monomers and hydrophilic monomers |
US7888709B2 (en) * | 2004-09-15 | 2011-02-15 | Sonetics Ultrasound, Inc. | Capacitive micromachined ultrasonic transducer and manufacturing method |
US8658453B2 (en) * | 2004-09-15 | 2014-02-25 | Sonetics Ultrasound, Inc. | Capacitive micromachined ultrasonic transducer |
US8309428B2 (en) * | 2004-09-15 | 2012-11-13 | Sonetics Ultrasound, Inc. | Capacitive micromachined ultrasonic transducer |
US7875036B2 (en) * | 2004-10-27 | 2011-01-25 | Vascular Control Systems, Inc. | Short term treatment for uterine disorder |
US8419656B2 (en) * | 2004-11-22 | 2013-04-16 | Bard Peripheral Vascular, Inc. | Post decompression marker introducer system |
JP2006288755A (en) * | 2005-04-11 | 2006-10-26 | Olympus Medical Systems Corp | Medical treatment device |
US10357328B2 (en) | 2005-04-20 | 2019-07-23 | Bard Peripheral Vascular, Inc. and Bard Shannon Limited | Marking device with retractable cannula |
DE102005018793A1 (en) * | 2005-04-22 | 2006-10-26 | Patent-Treuhand-Gesellschaft für elektrische Glühlampen mbH | Electronic ballast with phase dimmer detection |
US20070038088A1 (en) * | 2005-08-04 | 2007-02-15 | Rich Collin A | Medical imaging user interface and control scheme |
US20070049973A1 (en) * | 2005-08-29 | 2007-03-01 | Vascular Control Systems, Inc. | Method and device for treating adenomyosis and endometriosis |
CA2562580C (en) | 2005-10-07 | 2014-04-29 | Inrad, Inc. | Drug-eluting tissue marker |
US8430863B2 (en) * | 2005-12-02 | 2013-04-30 | Abbott Cardiovascular Systems Inc. | Visualization of a catheter viewed under ultrasound imaging |
US8303505B2 (en) * | 2005-12-02 | 2012-11-06 | Abbott Cardiovascular Systems Inc. | Methods and apparatuses for image guided medical procedures |
US7867169B2 (en) | 2005-12-02 | 2011-01-11 | Abbott Cardiovascular Systems Inc. | Echogenic needle catheter configured to produce an improved ultrasound image |
US8382674B2 (en) * | 2005-12-02 | 2013-02-26 | Abbott Cardiovascular Systems Inc. | Visualization of a catheter viewed under ultrasound imaging |
US7526339B2 (en) * | 2006-03-27 | 2009-04-28 | Medtronic, Inc. | IPG connector headers for implantable medical devices |
EP1867283A1 (en) * | 2006-06-13 | 2007-12-19 | Siemens Aktiengesellschaft | X-ray apparatus comprising germ blocking layer |
US7799022B2 (en) * | 2006-07-06 | 2010-09-21 | Boston Scientific Scimed, Inc. | Ablation with echogenic insulative sheath |
US9028859B2 (en) | 2006-07-07 | 2015-05-12 | Advanced Cardiovascular Systems, Inc. | Phase-separated block copolymer coatings for implantable medical devices |
US10639452B2 (en) * | 2006-07-13 | 2020-05-05 | Best Medical International, Inc. | Echo-opaque urethral catheter |
US20080071292A1 (en) * | 2006-09-20 | 2008-03-20 | Rich Collin A | System and method for displaying the trajectory of an instrument and the position of a body within a volume |
US20080071149A1 (en) * | 2006-09-20 | 2008-03-20 | Collin Rich | Method and system of representing a medical event |
US8064987B2 (en) | 2006-10-23 | 2011-11-22 | C. R. Bard, Inc. | Breast marker |
US9579077B2 (en) | 2006-12-12 | 2017-02-28 | C.R. Bard, Inc. | Multiple imaging mode tissue marker |
ES2432572T3 (en) | 2006-12-18 | 2013-12-04 | C.R. Bard, Inc. | Biopsy marker with imaging properties generated in situ |
GB0722406D0 (en) * | 2007-11-15 | 2007-12-27 | Smiths Group Plc | Medico-surgical assemblies and methods |
FR2926451B1 (en) * | 2008-01-21 | 2021-08-06 | Prodimed | DEVICE FOR SAMPLING OR TRANSFER INTO THE GENITAL ORGANS WITH IMPROVED ULTRA-SOUND VISIBILITY |
WO2009099767A2 (en) | 2008-01-31 | 2009-08-13 | C.R. Bard, Inc. | Biopsy tissue marker |
DE102008025878A1 (en) | 2008-05-29 | 2009-12-10 | Pajunk Gmbh & Co. Kg Besitzverwaltung | Cannula, especially for regional anesthesia |
JP5229473B2 (en) * | 2008-06-04 | 2013-07-03 | 財団法人ヒューマンサイエンス振興財団 | Ultrasound medical equipment |
DE102008040266A1 (en) | 2008-07-09 | 2010-01-14 | Biotronik Crm Patent Ag | Implantable measuring arrangement |
JP5523464B2 (en) * | 2008-09-22 | 2014-06-18 | カーディアック ペースメイカーズ, インコーポレイテッド | Styrene-isobutylene copolymer and medical device containing the same |
US9327061B2 (en) | 2008-09-23 | 2016-05-03 | Senorx, Inc. | Porous bioabsorbable implant |
US9782565B2 (en) | 2008-10-01 | 2017-10-10 | Covidien Lp | Endoscopic ultrasound-guided biliary access system |
US20110190662A1 (en) * | 2008-10-01 | 2011-08-04 | Beacon Endoscopic Corporation | Rapid exchange fna biopsy device with diagnostic and therapeutic capabilities |
US9186128B2 (en) | 2008-10-01 | 2015-11-17 | Covidien Lp | Needle biopsy device |
US8968210B2 (en) | 2008-10-01 | 2015-03-03 | Covidien LLP | Device for needle biopsy with integrated needle protection |
US9332973B2 (en) | 2008-10-01 | 2016-05-10 | Covidien Lp | Needle biopsy device with exchangeable needle and integrated needle protection |
US11298113B2 (en) | 2008-10-01 | 2022-04-12 | Covidien Lp | Device for needle biopsy with integrated needle protection |
WO2010077244A1 (en) | 2008-12-30 | 2010-07-08 | C.R. Bard Inc. | Marker delivery device for tissue marker placement |
US8315125B2 (en) * | 2009-03-18 | 2012-11-20 | Sonetics Ultrasound, Inc. | System and method for biasing CMUT elements |
US20100274276A1 (en) * | 2009-04-22 | 2010-10-28 | Ricky Chow | Aneurysm treatment system, device and method |
US8449466B2 (en) * | 2009-05-28 | 2013-05-28 | Edwards Lifesciences Corporation | System and method for locating medical devices in vivo using ultrasound Doppler mode |
JP2011005665A (en) * | 2009-06-23 | 2011-01-13 | Yasunori Fujimori | Reflector, and method for manufacturing the same |
US8788062B2 (en) * | 2009-08-04 | 2014-07-22 | Cardiac Pacemakers, Inc. | Polymer compression joining in implantable lead |
JP5463549B2 (en) * | 2009-09-08 | 2014-04-09 | 学校法人福岡大学 | Liposomes for ultrasound therapy and liposomes for promoting ultrasound therapy |
WO2011071778A1 (en) | 2009-12-07 | 2011-06-16 | Mayo Foundation For Medical Education And Research | Device for the delineation of cardiovascular or other anatomical structures |
US8480592B2 (en) | 2009-12-23 | 2013-07-09 | C. R. Bard, Inc. | Biopsy probe mechanism having multiple echogenic features |
EP2519307B1 (en) * | 2009-12-30 | 2015-09-09 | Cardiac Pacemakers, Inc. | Implantable leads with a unitary silicone component |
US8728562B2 (en) | 2009-12-30 | 2014-05-20 | Cardiac Pacemakers, Inc. | Implantable leads with a unitary silicone component |
US9085097B2 (en) * | 2010-03-01 | 2015-07-21 | Cook Medical Technologies Llc | Reinforced catheter or sheath with reduced friction surface |
US9955940B1 (en) | 2010-04-23 | 2018-05-01 | Avent, Inc. | Echogenic nerve block catheter and echogenic catheter tip |
WO2011163368A1 (en) * | 2010-06-24 | 2011-12-29 | Cdw Investments, Llc | Hyperechogenic needles |
US9254146B2 (en) * | 2010-10-18 | 2016-02-09 | Avent, Inc. | Echogenic nerve block apparatus and system |
WO2012145104A1 (en) * | 2011-04-20 | 2012-10-26 | Cardiac Pacemakers, Inc. | Ultrasonic monitoring of implantable medical devices |
EP2699186B1 (en) * | 2011-04-20 | 2020-11-04 | Koninklijke Philips N.V. | Real-time medical device visualization using nanomaterials |
US8987354B2 (en) * | 2011-04-25 | 2015-03-24 | Jingxu Zhu | Biocompatible polymer nanoparticle coating composition and method of production thereof |
CA2836379A1 (en) * | 2011-05-06 | 2012-11-15 | Edward H. Cully | Device with echogenic coating |
US20120283775A1 (en) * | 2011-05-06 | 2012-11-08 | Edward H Cully | Echogenic Sleeve |
DE102012100292A1 (en) * | 2012-01-13 | 2013-07-18 | Rm Temena Gmbh | Medical device |
US9381039B2 (en) | 2012-03-21 | 2016-07-05 | Medtronic, Inc. | Filling methods and apparatus for implanted medical therapy delivery devices |
EP2914310B1 (en) | 2012-10-31 | 2020-06-17 | Encapson B.V. | Medical devices with coatings for enhanced echogenicity |
EP2922478B1 (en) | 2012-11-21 | 2020-03-11 | C.R. Bard, Inc. | Core needle biopsy device |
US10292677B2 (en) | 2013-03-14 | 2019-05-21 | Volcano Corporation | Endoluminal filter having enhanced echogenic properties |
US20160030151A1 (en) | 2013-03-14 | 2016-02-04 | Volcano Corporation | Filters with echogenic characteristics |
US10219887B2 (en) | 2013-03-14 | 2019-03-05 | Volcano Corporation | Filters with echogenic characteristics |
JP2016517333A (en) | 2013-03-15 | 2016-06-16 | ボルケーノ コーポレイション | Distal protection system and method with pressure and ultrasound capabilities |
GB201312600D0 (en) * | 2013-07-13 | 2013-08-28 | Smiths Medical Int Ltd | Needle assemblies and methods |
USD716450S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD716451S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715442S1 (en) | 2013-09-24 | 2014-10-14 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715942S1 (en) | 2013-09-24 | 2014-10-21 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
PT3137126T (en) | 2014-04-30 | 2019-11-18 | Encapson B V | Medical devices with non-uniform coatings for enhanced echogenicity |
JP2017528263A (en) | 2014-09-24 | 2017-09-28 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Intraluminal filter with improved echogenic properties |
WO2016176509A1 (en) * | 2015-04-28 | 2016-11-03 | University Of Washington | Ferromagnetic shaped memory alloy nano-actuator and method of use |
US11147531B2 (en) | 2015-08-12 | 2021-10-19 | Sonetics Ultrasound, Inc. | Method and system for measuring blood pressure using ultrasound by emitting push pulse to a blood vessel |
GB2544261A (en) * | 2015-10-19 | 2017-05-17 | Taragenyx Ltd | Method |
DE102018209449A1 (en) * | 2018-06-13 | 2019-12-19 | Neuroloop GmbH | Medical implant, arrangement for implanting the medical implant and arrangement for detecting an intracorporeal movement pattern with the medical implant |
EP3888575A4 (en) * | 2018-11-29 | 2022-08-24 | Kitazato Corporation | Embryo transplanting tool and embryo transplanting apparatus |
US11504546B2 (en) | 2019-02-28 | 2022-11-22 | Cowles Ventures, Llc | Needle guidance device for brachytherapy and method of use |
US11524176B2 (en) | 2019-03-14 | 2022-12-13 | Cowles Ventures, Llc | Locator for placement of fiducial support device method |
NL2022839B1 (en) | 2019-03-29 | 2020-10-06 | Encapson B V | An echogenic coating for ultrasound imaging of medical devices in deep tissue layers. |
NL2022838B1 (en) | 2019-03-29 | 2020-10-06 | Encapson B V | Use of echogenic coating for ultrasound imaging of medical devices in deep tissue layers. |
US11364367B2 (en) | 2019-08-26 | 2022-06-21 | Covidien Lp | Medical fluid delivery |
JP7326597B2 (en) * | 2019-10-30 | 2023-08-15 | ボストン サイエンティフィック サイムド,インコーポレイテッド | endoscopic catheter device |
EP4180483A4 (en) * | 2020-07-08 | 2023-12-20 | Resonac Corporation | Resin composition, film, and cured product |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4219886A (en) * | 1978-10-16 | 1980-08-26 | The United States Of America As Represented By The Secretary Of The Navy | Multi-point reflective target system |
US4401124A (en) * | 1981-08-13 | 1983-08-30 | Technicare Corporation | Reflection enhancement of a biopsy needle |
US5289831A (en) * | 1989-03-09 | 1994-03-01 | Vance Products Incorporated | Surface-treated stent, catheter, cannula, and the like |
US5081997A (en) * | 1989-03-09 | 1992-01-21 | Vance Products Incorporated | Echogenic devices, material and method |
US5201314A (en) * | 1989-03-09 | 1993-04-13 | Vance Products Incorporated | Echogenic devices, material and method |
US5147631A (en) * | 1991-04-30 | 1992-09-15 | Du Pont Merck Pharmaceutical Company | Porous inorganic ultrasound contrast agents |
US5344640A (en) * | 1991-10-22 | 1994-09-06 | Mallinckrodt Medical, Inc. | Preparation of apatite particles for medical diagnostic imaging |
US5327891A (en) * | 1992-07-30 | 1994-07-12 | Rammler David H | Catheter track and catheter for diagnosis and treatment |
US5383466A (en) * | 1993-05-14 | 1995-01-24 | Becton, Dickinson And Company | Instrument having enhanced ultrasound visibility |
US5611345A (en) * | 1995-04-24 | 1997-03-18 | Hibbeln; John F. | Medical instrument with improved ultrasonic visibility |
US5921933A (en) * | 1998-08-17 | 1999-07-13 | Medtronic, Inc. | Medical devices with echogenic coatings |
-
1998
- 1998-08-17 US US09/135,468 patent/US5921933A/en not_active Expired - Lifetime
-
1999
- 1999-07-29 JP JP2000564679A patent/JP2002522167A/en active Pending
- 1999-07-29 CA CA002340746A patent/CA2340746A1/en not_active Abandoned
- 1999-07-29 EP EP99938891A patent/EP1105170B1/en not_active Expired - Lifetime
- 1999-07-29 WO PCT/US1999/017260 patent/WO2000009178A1/en active IP Right Grant
- 1999-07-29 DE DE69907475T patent/DE69907475T2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD669577S1 (en) | 2003-11-05 | 2012-10-23 | Kimberly-Clark Worldwide, Inc. | Cannula with band markings |
Also Published As
Publication number | Publication date |
---|---|
DE69907475D1 (en) | 2003-06-05 |
US5921933A (en) | 1999-07-13 |
WO2000009178A1 (en) | 2000-02-24 |
DE69907475T2 (en) | 2004-02-19 |
EP1105170B1 (en) | 2003-05-02 |
EP1105170A1 (en) | 2001-06-13 |
JP2002522167A (en) | 2002-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5921933A (en) | Medical devices with echogenic coatings | |
US5081997A (en) | Echogenic devices, material and method | |
US5201314A (en) | Echogenic devices, material and method | |
EP1264608B9 (en) | Composite material for medical applications, tube for medical applications and medical instrument | |
US5908413A (en) | Radiopaque catheter and method of manufacture thereof | |
US5289831A (en) | Surface-treated stent, catheter, cannula, and the like | |
US9241773B2 (en) | Imaging fiducial markers and methods | |
CN105686866B (en) | Echogenic nerve block equipment and system | |
US20070100279A1 (en) | Radiopaque-balloon microcatheter and methods of manufacture | |
US6371943B1 (en) | Spring tip needle combination | |
JP2007528779A (en) | Markers for visualization with MRI and X-ray | |
US20130204232A1 (en) | Unknown | |
CN112755363B (en) | Micro-catheter system | |
MX2007004589A (en) | Catheter. | |
JP2023144058A (en) | Echogenic catheter and catheter system | |
EP0970715B1 (en) | Flow directed catheter having radiopaque strain relief segment | |
JP3761214B2 (en) | Medical guidewire | |
JP3761216B2 (en) | Medical guide wire and manufacturing method thereof | |
WO2007065420A1 (en) | Catheter tube | |
JPH01121064A (en) | Catheter | |
JP2839617B2 (en) | Tube with contrast agent | |
JPH06154334A (en) | Catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |